Fentanyl System Patch
Product Images NDC 47781-424

19 FDA label images from Alvogen · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Fentanyl System (NDC 47781-424). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alvogen, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Fen09 0001 01)

Structural Formula (Fen09 0001 01)
Chemical structure diagram of fentanyl, the active ingredient in the Fentanyl system transdermal patch by ALVOGEN. The illustration shows the molecular arrangement of atoms and bonds characteristic of fentanyl's chemical formula.*
FDA Label Image

Parts Of The Fentanyl Transdermal System Patch (Fen09 0001 02)

Parts Of The Fentanyl Transdermal System Patch (Fen09 0001 02)
An instructional diagram showing the layers of a transdermal fentanyl patch. The diagram labels the release liner, the drug-containing layer, and the backing layer, illustrating the patch's construction.*
FDA Label Image

Figure 1 (Fen09 0001 03)

Figure 1 (Fen09 0001 03)
A line graph showing fentanyl concentration (ng/mL) over time (hours) for Fentanyl Transdermal System 100 mcg/h applied once versus four times. The graph compares the plasma fentanyl concentration profiles, depicting mean values with error bars, indicating variability over approximately 340 hours.*
FDA Label Image

Parts Of The Fentanyl Transdermal System Patch (Fen09 0001 04)

Parts Of The Fentanyl Transdermal System Patch (Fen09 0001 04)
An instructional diagram illustrating the layers of a fentanyl transdermal patch. The image labels the three components: the release liner, the drug-containing layer, and the backing layer, demonstrating the patch's structure.*
FDA Label Image

Figure A (Fen09 0001 05)

Figure A (Fen09 0001 05)
An instructional photograph showing the placement of a single fentanyl transdermal patch on the upper chest area of a person's torso. The patch is positioned on the skin, illustrating correct application for transdermal drug delivery.*
FDA Label Image

Figure B (Fen09 0001 06)

Figure B (Fen09 0001 06)
Black and white instructional illustration showing a human back with a single transdermal fentanyl patch applied to the upper shoulder area. The image demonstrates the appropriate placement site for the Fentanyl system patch.*
FDA Label Image

Figure C (Fen09 0001 07)

Figure C (Fen09 0001 07)
Illustration showing the correct placement of a Fentanyl transdermal patch on the side of the torso of a male figure. The patch is depicted applied to the skin below the chest area, demonstrating proper application for the Fentanyl system patch.*
FDA Label Image

Figure D (Fen09 0001 08)

Figure D (Fen09 0001 08)
An illustration showing a person with a Fentanyl system transdermal patch applied to the upper arm. The patch is a small, square, white adhesive applied to the skin, demonstrating proper placement on the body for medication delivery.*
FDA Label Image

Figure E (Fen09 0001 09)

Figure E (Fen09 0001 09)
An instructional illustration showing a man applying a fentanyl transdermal patch to the upper chest area below the shoulder. The image demonstrates proper placement of the patch on the skin for transdermal drug delivery.*
FDA Label Image

Figure F (Fen09 0001 10)

Figure F (Fen09 0001 10)
An instructional illustration showing hands applying or handling a Fentanyl transdermal patch. The image demonstrates the proper use or placement technique of the patch for prescribed transdermal delivery.*
FDA Label Image

Figure G (Fen09 0001 11)

Figure G (Fen09 0001 11)
An instructional illustration showing two hands applying a Fentanyl transdermal patch on the skin. The image demonstrates the proper technique for using the Fentanyl system patch.*
FDA Label Image

Figure H (Fen09 0001 12)

Figure H (Fen09 0001 12)
An instructional grayscale illustration showing a person applying a transdermal patch to the upper chest area, demonstrating proper placement of the Fentanyl system patch for transdermal administration.*
FDA Label Image

Figure I (Fen09 0001 13)

Figure I (Fen09 0001 13)
An illustration showing hands demonstrating how to use or apply a transdermal patch, likely related to the Fentanyl system transdermal patch product. The image focuses on hand positioning and preparation steps.*
FDA Label Image

Figure J (Fen09 0001 14)

Figure J (Fen09 0001 14)
An instructional image showing a person disposing of a used Fentanyl transdermal patch by placing it into a toilet. The image emphasizes proper disposal of the patch to prevent accidental exposure.*
FDA Label Image

Principal Display Panel (12 mcg/h Patch Carton)

Principal Display Panel (12 mcg/h Patch Carton)
Fentanyl Transdermal System patch packaging label for 12 mcg/h strength. The label shows the brand name, dosage form as patch, and transdermal route. It includes warnings, inactive ingredients, usage instructions, bar code, and is labeled for opioid tolerant patients only. Manufactured by Kindeva Drug Delivery L.P. and distributed by Alvogen, Inc. The package contains five patches delivering 12 mcg/h fentanyl for 72 hours.*
FDA Label Image

Principal Display Panel (25 mcg/h Patch Carton)

Principal Display Panel (25 mcg/h Patch Carton)
Packaging label for Fentanyl Transdermal System 25 mcg/h patch by Alvogen. The label is yellow with black text and includes warnings, inactive ingredients, usage instructions, and safety information. It indicates a box containing five patches of 25 mcg/h strength, intended for opioid-tolerant patients only. Manufacturer is Kindeva Drug Delivery LP, Northridge, CA.*
FDA Label Image

Principal Display Panel (50 mcg/h Patch Carton)

Principal Display Panel (50 mcg/h Patch Carton)
Packaging label for Fentanyl Transdermal System 50 mcg/h patch by Alvogen. The label includes usage warnings, inactive ingredients, and distributor information. The package contains five 50 mcg/h fentanyl transdermal systems for human prescription use, marked for opioid-tolerant patients only. The label provides storage instructions and a Medication Guide advisory.*
FDA Label Image

Principal Display Panel (75 mcg/h Patch Carton)

Principal Display Panel (75 mcg/h Patch Carton)
Packaging label for Fentanyl Transdermal System 75 mcg/h patch by Alvogen. The carton is yellow with blue and black text, displaying strength and delivery rate prominently. It includes safety warnings, usage instructions, inactive ingredients, and contact information for Alvogen, with a note that the product is for opioid-tolerant patients only. The label indicates a package of five systems.*
FDA Label Image

Principal Display Panel (100 mcg/h Patch Carton)

Principal Display Panel (100 mcg/h Patch Carton)
Fentanyl Transdermal System 100 mcg/h patch packaging label from Alvogen. The yellow label includes directions for use, safety warnings about serious breathing problems, and states it is for opioid tolerant patients only. It contains five 100 mcg/h fentanyl patches, each delivering medication over 72 hours. The label advises to keep out of reach of children and includes contact information for Alvogen.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.